NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Flex Ltd. (NASDAQ: FLEX) will be discussing their earnings results in their Q4 Earnings Call to be held April 27, 2017 at 5:00 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/24126.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/24126.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460862

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Skyworks Solutions, Inc. (NASDAQ: SWKS) will be discussing their earnings results in their Q2 Earnings Call to be held April 27, 2017 at 5:00 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/22895

Replay Information

The replay will be available online at https://www.investornetwork.com/company/22895

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460860

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Green Bancorp, Inc. (NASDAQ: GNBC) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 5:00 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/24246.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/24246.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460861

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Senomyx, Inc. (NASDAQ: SNMX) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 5:00 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/22812.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/22812.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460858

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Microsemi Corporation (NASDAQ: MSCC) will be discussing their earnings results in their Q2 Earnings Call to be held April 27, 2017 at 4:45 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/22240.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/22240.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460851

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Alphabet Inc. Class A (NASDAQ: GOOG) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 4:30 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/24261

Replay Information

The replay will be available online at https://www.investornetwork.com/company/24261

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460849

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Sarepta Therapeutics, Inc. (NASDAQ: SRPT) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 4:30 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/22853

Replay Information

The replay will be available online at https://www.investornetwork.com/company/22853

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460846

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Helen of Troy Limited (NASDAQ: HELE) will be discussing their earnings results in their Q4 Earnings Call to be held April 27, 2017 at 4:45 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/24326.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/24326.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 460850

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased TherapeuticsMD, Inc. (“TherapeuticsMD”) (NYSE MKT: TXMD) securities between July 7, 2016 and April 9, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sa/therapeuticsmd-inc?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) the Company’s New Drug Application (NDA) submission for TX-004HR was deficient; (ii) the Company’s NDA submission for TX-004HR was not supported by the complete TX-004HR clinical program and/or the clinical program was deficient; (iii) the Company’s deficient NDA would likely cause a delay of the FDA’s potential approval of the TX-004HR NDA.

If you suffered a loss in TherapeuticsMD you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/therapeuticsmd-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 460832

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Lion Biotechnologies, Inc. (“Lion Biotechnologies”) (NASDAQ: LBIO) securities between November 14, 2013 and April 10, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sa/lion-biotechnologies-inc?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) through its former CEO, Manish Singh, Lion was engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting the Company to potential investors that purported to be independent from the company when, in truth, they were paid promotions; (2) Singh engaged a notorious stock promotion firm to pay writers to publish articles about Lion on investment websites, as well as to coordinate the distribution of articles to thousands of electronic mailboxes; (3) Singh actively participated in the promotional work for the Company and understood that the promotion firm was using writers who would not disclose that Lion was indirectly compensating them for their publications; and (4) consequently, defendants’ public statements were materially false and misleading at all relevant times.

If you suffered a loss in Lion Biotechnologies, you have until June 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/lion-biotechnologies-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 460826